Diabetes care -too complicated for primary health care?;Er diabetesbehandling for vanskelig for allmennpraktikeren alene?

Tidsskrift for den Norske Laegeforening

Volumn 120, Issue 22, 2000, Pages 2678-2682

  Claudi, Tor ^a   Cooper, John G ^b   Daae, Cecilie ^c  

^a Rønvik Legesenter   (Norway)

^b STAVANGER UNIVERSITY HOSPITAL   (Norway)

^c Bjerke Legesenter   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT;

CARDIOVASCULAR DISEASE; CLINICAL COMPETENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIABETIC ANGIOPATHY; GENERAL PRACTICE; HEALTH CARE QUALITY; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; NORWAY; NURSING; PRACTICE GUIDELINE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK FACTOR; STANDARD;

ANTIHYPERTENSIVE AGENTS; CARDIOVASCULAR DISEASES; CLINICAL COMPETENCE; CONTROLLED CLINICAL TRIALS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FAMILY PRACTICE; HUMANS; HYPOGLYCEMIC AGENTS; NORWAY; PRACTICE GUIDELINES; PROSPECTIVE STUDIES; QUALITY ASSURANCE, HEALTH CARE; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS;

EID: 0034692323     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Lauritzen T, Frost-Larsen K, Larsen H-W, Deckert T and the Steno Study Group (1985). Two-year experience with continous subcutaneous insuline infusion in relation to retinopathy and albuminuria. Diabetes 1985; 35 (suppl 3): 74-9.
2. Brinchmann-Hansen O, Dahl-Jørgensen K, Sandvik L Hanssen KF. Blood glucose consentrations and progression of diabetic retinopathy: the seven year results of the Oslo-study. BMJ 1992; 304: 19-22.
3. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993; 329: 977-86.
4. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352: 837-53.
5. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995; 28: 103-17.
6. Andersson DK, Svardsudd K. Long-term glycemic control relates to mortality in type II diabetes. Diabetes Care 1995; 18: 1534-43.
7. Adler AI, Neil HA, Manley SE, Holman RR, Turner RC. Hyperglycemia and hyperinsulinemia at diagnosis of diabetes and their association with subsequent cadiovascular disease in the United Kingdom prospective diabetes study (UKPDS 47). Am Heart J 1999; 138: 353-9.
8. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352: 854-65.
9. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 1998; 317: 703-13.
10. Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group Lancet 1998; 351: 1755-62.
11. Goldberg RB, Mellies MJ, Sacks FM, Moye LA, Howard BV, Howard WJ et al. Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investigators. Circulation 1998; 98: 2513-9.
12. Pyorala K, Pedersen TR, Kjekshus J, Faergeman O, Olsson AG, Thorgeirsson G. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care 1997; 20: 614-20.
13. Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982; 1: 1430-2.
14. Gilbert RE, Cooper ME, McNally PG, O'Brien RC, Taft J, Jerums G. Microalbuminuria: prognostic and therapeutic implications in diabetes mellitus. Diabet Med 1994; 11: 636-45.
15. Yudkin JS, Chaturvedi N. Developing risk stratification charts for diabetic and nondiabetic subjects. Diabet Med 1999; 16: 219-27.
16. Daae C. Handlingsprogrammer og guidelines - redning eller refselse. Utposten 1998; 27: 31-4.
17. Claudi T, Cooper JG, Daae C, Midthjell K, Furuseth K, Hanssen KF. NSAMs handlingsprogram for diabetes i allmennpraksis. Skriftserie for leger: Utdanning og kvalitetssikring. Oslo: Norsk selskap for allmennmedisin, Den norske lægeforening, Norges Diabetesforbund, Statens institutt for folkehelse, 2000.
18. Midthjell K, Bjørndal A, Holmen J, Krüger O, Bjartveit K. Prevalence of known and previously unknown diabetes mellitus and impaired glucose tolerance in an adult Norwegian population. Indications of an increasing diabetes prevalence. The Nord-Trøndelag Diabetes Study. Scand J Prim Health Care 1995; 13: 229-35.
19. Midthjell K, Krüger O, Holmen J, Tverdal A, Claudi T, Bjørndal A et al. Rapid changes in the prevalence of obesity and known diabetes in an adult Norwegian population. The Nord-Trøndelag Health Surveys: 1984- 1986 and 1995-1997. Diabetes Care 1999; 22: 1813-20.
20. Hetlevik I, Holmen J, Midthjell K. Treatment of diabetes mellirus-physicians' adherence to clinical guidelines in Norway. Scand J Prim Health Care 1997; 15: 193-7.
21. Claudi T, Cooper J, Skogøy K, Hausken MF, Melbye H. Diabetesomsorg i norsk allmennpraksis. En tilstandsrapport fra Salten og deler av Rogaland. Tidsskr Nor Lægeforen 1997; 117: 3661-4.
22. Dunn NR, Bough P. Standards of care of diabetic patients in a typical English community. Br J Gen Pract 1996; 46: 401-5.
23. Kristensen JK, Bro F, Lauritzen T. Kvalitetsvurdering af diabetesomsorgen i en større lægepraksis. Ugeskr Læger 1999; 161: 940-4.
24. Wandell PE, Brorsson B, Aberg H. Diabetic patients in primary health care-quality of care three years apart. Scand J Prim Health Care 1998; 16: 44-9.
25. Alberti KG, Gries FA. Management of non-insulin-dependent diabetes mellitus in Europe: a concensus view. Diabet Med 1988; 5: 275-81.
26. Birkeland KI, Claudi T, Hansteen V, Hanssen KF, Hjermann I et al. Forebygging av hjerteog karsykdom ved type 2-diabetes. Tidsskr Nor Lægeforen 2000; 120: 2554-9.
27. Gæde P, Vedel P, Parving H-H, Pedersen O. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. Lancet 1999; 353: 617-22.
28. Hetlevik I. Den fulle allmennmedisinske bøtten. Tidsskr Nor Lægeforen 1999; 119: 3547-8.
29. Gidske G, Christensen NG, Jevnaker M, Skurtveit KJ, Thue G, Klovning A et al. Bedre kvalitet på trombotestanalyser utført i allmennpraksis. Resultatar fra NOKLUS' utsendelser i 1993-97. Tidsskr Nor Lægeforen 1998; 118: 1196-200.
30. Carlsen T, Bratland SZ, Claudi T, Cooper J, Telje J, Waaler HM et al. Effektiv læring med data fra egen praksis - erfaringer fra SATS-prosjektet. Tidsskr Nor Lægeforen 1999; 119: 4306-9.
31. Joshi MS, Bernard DB. Clinical performance improvement series. Classic CQi integrated with comprehensive disease management as a model for performance improvement. Jt Comm J Qual Improv 1999; 25: 383-95.
32. Solberg LI, Reger LA, Pearson TL, Cherney LM, O'Connor PJ, Freemen SL et al. Using continuous quality improvement to improve diabetes care in populations: the IDEAL model. Improving care for diabetics through empowerment active collaboration and leadership. Jt Comm J Qual Improv 1997; 23: 581-92.
33. Deichmann RE, Castello E, Horswell R, Friday KE. Improvements in diabetic care as measured by HbAlc after a physician education project. Diabetes Care 1999; 22: 1612-6.
34. Olivarius ND, Lauritzen T, Beck-Nielsen H, Fog J, Mogensen CE. Co-ordination of diabetes care in the primary and the secondary health care system in Denmark. Danish National Board of Health. Diabet Med 1994; 11: 123-5.
35. Makela M. Do general practitioners need guidelines? Scand J Prim Health Care 1996; 14: 2-3.
36. Dunn N, Pickering R. Does good practice organization improve the outcome of care for diabetic patients? Br J Gen Pract 1998; 48: 1237-40.
37. Cooper JG. Diabetes i primærhelsetjenesten - slik gjør vi på Hjelmeland. Utposten 1995; 24: 92-4.